Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Julphar
Queensland Health
Merck
Novartis
McKinsey
Accenture
Cipla
Teva

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022046

« Back to Dashboard

NDA 022046 describes BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE profile page.

The generic ingredient in BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE is bupivacaine hydrochloride; epinephrine bitartrate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for 022046
Tradename:BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE
Applicant:Hospira
Ingredient:bupivacaine hydrochloride; epinephrine bitartrate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.5%;0.0091MG/ML
Approval Date:Jul 13, 1983TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Argus Health
Accenture
Teva
Boehringer Ingelheim
Moodys
Fuji
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot